Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial

Overview of attention for article published in The Lancet, April 2012

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 3 news outlets
policy: 2 policy sources
twitter: 12 X users

facebook: 3 Facebook pages
googleplus: 1 Google+ user
guideline: 2 clinical guideline sources

Readers on

mendeley: 274 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

Do Treg Cells Block Mom-to-Baby HIV Transmission?

MedPage Today, 12 Jun 2018

Action Points Note that this study was published as an abstract and presented at a conference.

News story from AllAfrica on Wednesday 09 December 2015

AllAfrica, 09 Dec 2015

Lopinavir-ritonavir prophylaxis not superior to lamivudine in preventing HIV in breastfeeding infants [ANRS 12174 trial] | 2 Minute Medicine

2 Minute Medicine , 27 Nov 2015

1. This randomized controlled trial showed that prophylaxis with lopinavir-ritonavir was not superior to lamivudine in…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.